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Spotlight on. . .
Vladimir SkulachevWith his pioneering work on non-phosphorylating respira-
tion, mitochondrial membrane potential and reactive oxygen
species (ROS) in mitochondria, Prof. Vladimir Skulachev
could be considered a founder of the discipline of ‘‘Bioenerget-
ics’’. His long and successful career at the Moscow State
University, where he is now Director of the Belozersky Insti-
tute of Physicochemical Biology, has led him through very try-
ing economical and political times, in spite of which his interest
in science and passion for research never wavered. He has been
a FEBS Letters Editor since 1988 and certainly one of the most
prominent contributors to the journals success.You have become famous through the media for your ‘‘quest
against aging’’. How do you deﬁne aging?
I consider aging a slow suicide used by nature as a mecha-
nism to accelerate evolution [1,2]. Evolution solely driven by
spontaneous mutations would otherwise be too slow. Imagine
two hares, a clever one and a stupid one, being chased by a fox.
If the hares are young, their muscles are strong, and they will
both easily escape the fox. When the hares become older, they
will be aﬀected by muscle wasting as a sign of aging, and they
will run slower. However, the clever hare will probably start
running before the stupid one, and have more chances of sur-
viving and producing clever leverets. This is how aging may be
advantageous for natural selection.Couldnt aging simply be the consequence of the accumulation of
toxic insults that ultimately result in death?
No, there is more to it than that. Aging and certain other
kinds of death are triggered by special genetic programs. It is
by now clear to me that each complex biological system can
execute self-elimination programs. There is a Samurai law that
rules over biology: if a system is unnecessary or even harmful
to other systems of higher hierarchy, it will commit suicide [3].
Very often, ROS play the role of a ritual knife in such an event.
Undoubtedly, ROS are involved in apoptosis, necrosis and the
execution of self-elimination programs. A burst of ROS will
destroy the mitochondrion (mitoptosis), and massive mitopto-
sis eventually causes cell death (apoptosis). There are clear
cases of programmed organoptosis during ontogenesis, medi-
ated by massive apoptosis such as the reabsorption of the tail
in tadpole or in the human embryo. When a whole organism is0014-5793/$34.00  2008 Federation of European Biochemical Societies. Pu
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trolled phenoptosis.What is your approach against aging?
I am using a biochemical approach. The idea is to target a
powerful rechargeable antioxidant such as plastoquinone
(originally used by the chloroplast) to the mitochondrion to
prevent an age-related increase in the ROS level. Thanks to
the electric potential present in the mitochondrion, a mem-
brane-permeable substance with a positive charge is able to
penetrate into a cell and speciﬁcally enter the mitochondria
that are negatively charged inside [4]. We have developed a ser-
ies of hydrophobic compounds in which the positive charge of
a phosphorus or nitrogen is dislocated on aromatic rings, so
that the ion is not surrounded by water dipoles. David Green
named these compounds ‘‘Skulachev ions’’ (Sk+ and Sk). In
mitochondria, Sk+ works like an electrolocomotive [5,6]. As
a result, the antioxidant (plastoquinone) conjugated to Sk+
(we called it SkQ) is speciﬁcally targeted to mitochondria [7].What are the eﬀects of Skulachev ions?
The eﬀects are rather striking! Just by adding SkQ to the
food, the median life span of drosophila will increase by
15%, and that of mice by 100% [7]. Recently, Barbara Can-
nons group in Stockholm has tested the ions on mice that car-
ry a mutation in the proofreading domain of mitochondrial
DNA polymerase. In these mice, aging is accelerated by a fac-
tor of three, but if they are treated with SkQ, they live 30%
longer. The compound has also successfully been used to treat
retinopathies and uveitis, and the rate of healing is very high.
In fact, the compound will soon be commercially available in
the form of eye-drops for veterinary use. The next step should
be trials on humans.Does this mean that these antioxidants may make us live much
longer?
Not exactly, SkQ strongly decreases probability of death at
early and middle stages of aging. As to the maximal life span of
all the animals tested, it increased only slightly as a result of
the SkQ treatment. However, despite their age, the animals
are dying without appearance of the typical traits of senes-
cence. Thus, we are ﬁghting ﬁrst of all senescence, not mortal-
ity at very old ages.Couldnt the ions cause some side eﬀects, such as promoting
cancer?
Up to now, no side eﬀects were observed. The doses of
antioxidant are so small (in mice, down to 0.2 lg/kg per day)
that they can hardly harm the organism. Apoptosis of trans-
formed cells, as a defence mechanism against cancer, may stillblished by Elsevier B.V. All rights reserved.
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strong increase in mitochondrial ROS, which mediates aging.I imagine it must have been diﬃcult under the Soviet government
to keep politics separate from science. How did the fall of
Communism aﬀect your research?
When I was a postdoc, I was invited by Albert Lehninger to
join his lab in Baltimore. However, the Soviet authorities never
released the permission for me to leave the country, on the
grounds that they were ‘‘investigating’’. I realized later that
the reason was that I was not a member of the Communist
Party. Today, fortunately, I can travel without any problem.
Also funding has changed radically. Previously, money came
exclusively from the state, and every aspect of a research
project had to be approved by the authorities. You could be
arrested even if you were found with ten undeclared dollars
in your pocket. Today my gerontological research is mainly
funded privately by Mr. O.V. Deripaska, one of the richest
businessmen in Russia. Mr. Deripaska has graduated from
the faculty of Physics, Moscow State University, and
understands the importance of investing in research. In fact,pharmaceutical companies are already showing interest in
our compounds for a variety of possible applications.References
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